# 2026 Nobel Prize in Medicine: Optogenetics: a light switch for brain cells > The 2026 Medicine prize honours optogenetics: a way to switch chosen nerve cells on or off with flashes of light. Peter Hegemann and Georg Nagel found the key part in a single-celled green alga, whose protein channelrhodopsin opens a tiny gate in the cell surface the moment light hits it. Karl Deisseroth put that protein into nerve cells and then into the brains of living mice. That gave neuroscience a way to test which cells actually cause a memory, a feeling or a behaviour. - Laureates: Karl Deisseroth (share 1/3, Howard Hughes Medical Institute and Stanford University, USA); Peter Hegemann (share 1/3, Humboldt University of Berlin, Berlin, Germany); Georg Nagel (share 1/3, University of Würzburg, Würzburg, Germany) - Official citation: “for their discoveries concerning light-gated ion channels and optogenetics” - Course page: https://nobelexplained.com/medicine/2026-optogenetics - Last updated: 2026-10-10 ## Explained simply (ELI5) Your brain holds around 90 billion nerve cells, wired together like a giant tangle of fairy lights. For a long time scientists could only watch the tangle flicker. They could not reach in, flip one small group of bulbs, and see what happened. The answer came from a tiny green alga that swims toward light. On its surface sits a protein that works like a **door with a light sensor built in**. When blue light hits it, the door swings open and charged particles rush into the cell. In a nerve cell, that rush is how a signal starts. > **Borrow the door** Scientists copied the alga's gene for this door into chosen nerve cells of mice. Now a flash of blue light makes those cells fire and leaves their neighbours alone. Switch the light on and watch: a whisker twitches, a sleeping mouse wakes up, or an old fear memory comes back. That is **optogenetics**: teach a chosen nerve cell to listen to light, then use light to ask it what it does. **Video transcript (36 seconds):** Tiny green algae in a dish swim toward a lamp. Peter Hegemann guessed that one protein on each alga works like a door with a light sensor. Georg Nagel showed he was right. Blue light makes the door swing open, and charged bits rush in. In a brain cell, that rush starts a signal. The 2026 Nobel Prize in Physiology or Medicine went to them and to Karl Deisseroth, who put the door into mouse brain cells. A flash of light made a mouse move its whiskers. ## Explained for undergraduates Nerve cells talk in electrical pulses. A pulse begins when **ion channels**, protein pores in the cell membrane, open and let positive ions flow in. That inflow makes the inside of the cell less negative. If the change is big enough, the cell fires an **action potential**, a brief spike that passes the message on. In the early 1990s **Peter Hegemann**, at the Max Planck Institute for Biochemistry in Martinsried, recorded how the green alga **Chlamydomonas** reacts to light. An electrical impulse appeared about half a millisecond after a flash. In the human eye, light triggers a chain of chemical steps before a channel opens, which takes at least 10 milliseconds. Hegemann proposed that the alga skips the chain: one protein both catches light and forms the channel. Many doubted him: no known ion channel responded to light alone. > **Frog eggs that respond to light** Around 2000, Japanese researchers released thousands of Chlamydomonas gene sequences. Hegemann's group found two that resembled light-capturing proteins and sent them to Georg Nagel at the Max Planck Institute of Biophysics in Frankfurt. Nagel made frog eggs produce each protein in their membranes. Under light, ions flowed through them: they were light-gated ion channels, now called channelrhodopsin-1 and channelrhodopsin-2. Channelrhodopsin-2 opened within 0.2 milliseconds, let positive ions in, and also made human and hamster kidney cells light sensitive. **Karl Deisseroth**, then starting a lab at Stanford, asked Nagel for the gene. His team put it into rat nerve cells grown in a dish. Blue light made the cells fire. The result came out in 2005. In 2007 the team delivered the gene to one type of nerve cell in the motor cortex of living mice, shone light through a thin optical fibre, and made the whiskers move. - **Early 1990s**: Hegemann proposes that one protein senses light and is the channel. - **2002**: Channelrhodopsin-1 shown to be a light-gated channel. - **2003**: Channelrhodopsin-2 makes frog eggs and kidney cells light sensitive. - **2005**: Deisseroth's lab fires rat nerve cells with blue light. - **2006**: The method is named optogenetics. - **2007**: Light moves whiskers and wakes sleeping mice. The power comes from genetics. Researchers deliver the gene, often with a modified virus, so that only one chosen type of nerve cell makes the channel. Only that type then responds to light. Scientists could now switch a defined cell type on and test whether it **causes** a behaviour. Before, they could mostly show that the two happen together. **Video transcript (60 seconds):** In Frankfurt, Georg Nagel injected alga genes into frog eggs. Under light, ions flowed into them. In the early 1990s, Peter Hegemann proposed that one protein in the alga Chlamydomonas catches light and forms a channel. In 2002 and 2003, Nagel showed he was right. The alga's channelrhodopsin-2 opens within 0.2 milliseconds. In a nerve cell, the positive ions it lets in trigger an action potential, an electrical spike. Karl Deisseroth put the gene into rat nerve cells, and blue light made them fire. In 2007, light on one type of brain cell woke sleeping mice. Nagel and Hegemann share the 2026 Nobel Prize in Physiology or Medicine with Deisseroth. Researchers can now switch on one kind of cell and see what it does. ## Explained for experts In 1999 Francis Crick argued that understanding the brain would need a way to switch one neuron type on or off in an alert animal while leaving its neighbours alone, and he named light as the ideal signal. Earlier tools each missed a requirement. Miesenböck's chARGe (2002) needed three Drosophila genes and a G-protein cascade, so spike timing was loose. P2X2 receptors with caged ATP, and photoswitchable tethered ligands on engineered potassium channels, needed a chemical delivered from outside. What was missing was **one genetically encoded protein that turns a photon directly into membrane current within milliseconds**. > **Receptor and pore in one molecule** Channelrhodopsins are seven-transmembrane microbial rhodopsins with a bound retinal. A photon isomerises retinal from all-trans to 13-cis, which opens the pore; the retinal relaxes back within milliseconds and the pore closes. In Xenopus oocytes Nagel showed in 2002 that ChR1 passes mostly protons under green light. In 2003 ChR2 proved to be a non-selective cation channel driven by blue light (peak near 480 nm), with a transient peak current that settles to a lower plateau under steady light. The first 315 amino acids kept the light-gated current, and reversal-potential shifts confirmed passive inward cation flow down the electrochemical gradient. Two properties made ChR2 the right actuator. First, it is a **channel, not a pump**. Archaeal pumps such as halorhodopsin move one ion per absorbed photon; a channel lets many ions run down their gradient, fast enough to match action potentials. Second, Nagel noticed that the trace retinal already in mammalian cells is enough, so no chromophore has to be added. Boyden, Zhang, Bamberg, Nagel and Deisseroth used this in 2005 to drive spike trains in cultured hippocampal neurons with millisecond precision. In 2007 Aravanis and colleagues in the Deisseroth lab coupled laser diodes to optical fibres, expressed ChR2 in layer 5 excitatory neurons of the vibrissal motor cortex, and evoked whisker movements in vivo. > **Off switches and new colours** In 2007 two groups (Zhang and colleagues in the Deisseroth lab, and Han and Boyden) expressed the chloride pump halorhodopsin from Natronomonas pharaonis in neurons. Yellow light hyperpolarised the cells and silenced spiking, and its red-shifted spectrum allowed two-colour control alongside ChR2. Because pumps are inefficient, channelrhodopsins were later engineered to conduct chloride (2014), and in 2015 John Spudich's lab found natural anion channelrhodopsins, GtACR1 and GtACR2, in the alga Guillardia theta. **What causal control revealed** - Arousal: driving hypocretin (orexin) neurons in the lateral hypothalamus raised the chance of waking from slow-wave and REM sleep, with latency set by stimulation frequency (Adamantidis et al., 2007). - Memory: reactivating dentate gyrus cells tagged during fear conditioning made mice freeze in a neutral context (Liu et al., 2012, Tonegawa lab), and a false fear memory could be implanted (Ramirez et al., 2013). - Valence: intermingled dopamine neurons in the ventral tegmental area drive reward or aversion depending on input, from the laterodorsal tegmentum or the lateral habenula (Lammel et al., 2012). - Anxiety: activating basolateral-to-central amygdala projections reduced anxiety-like behaviour (Tye et al., 2011). Clinical use is **early and experimental**. In 2006 Zhuo-Hua Pan's group restored light responses in degenerated mouse retinas with AAV-delivered ChR2 in retinal ganglion cells. In 2021 Sahel, Roska and colleagues injected an AAV encoding the red-shifted channel ChrimsonR into a blind patient with retinitis pigmentosa; with goggles projecting light pulses onto the retina, the patient could distinguish high-contrast objects on a table, and EEG showed object-related visual cortex activity. That was one case. **Video transcript (63 seconds):** On a psychiatric ward, medical student Karl Deisseroth saw how rarely treatments worked. Years later he wrote to Georg Nagel for the DNA of channelrhodopsin-2. The protein is a light sensor and a pore in one. Blue light twists its retinal from all-trans to 13-cis. A non-selective cation pore opens, and positive ions flow in. Peter Hegemann, who shares the 2026 prize, proposed this protein in the early 1990s. In 2002 and 2003, Nagel showed it in frog oocytes. In 2005, Deisseroth's lab drove spikes in cultured hippocampal neurons with millisecond precision and no added retinal. In 2007, the chloride pump halorhodopsin added a yellow-light off switch. In a 2021 research study, one blind patient with retinitis pigmentosa received a channel tuned to red light, ChrimsonR, and regained partial vision with light-projecting goggles. ## Think first **Q:** A green alga makes an electrical signal about half a millisecond after light hits it. Your eye needs at least 10 milliseconds. What would you guess makes the alga so much faster? **A:** **It skips the relay race.** In your eye, light sets off a chain of chemical steps before an ion channel finally opens. Peter Hegemann guessed that in the alga a single protein both catches the light and is the channel. He was right, and that protein, channelrhodopsin, became the switch at the heart of optogenetics. **Q:** You put an alga gene into a mouse's nerve cells. The protein it makes needs a light-catching molecule called retinal. Do you also have to feed retinal to the mouse? **A:** **No.** Georg Nagel noticed that the small amount of retinal already present in animal cells is enough. Deisseroth's team later confirmed this in living mice. So one gene plus a light source does the whole job, which is a big reason the method spread to labs around the world so quickly. ## Crick called it far-fetched In 1999 Francis Crick wrote that light would be the ideal signal for switching one type of neuron on and off in an awake animal, and admitted the idea sounded far-fetched. Eight years later, blue light sent down a fibre into a living mouse's brain moved its whiskers, using a protein borrowed from a single-celled green alga. ## Key terms - **Optogenetics**: A method that puts a light-sensitive protein into chosen cells with genetics, so that light can switch those cells on or off. - **Channelrhodopsin**: A protein from green algae that acts as both a light sensor and an ion channel. When light hits it, its pore opens and ions flow through. - **Ion channel**: A protein pore in a cell membrane that opens to let charged atoms (ions) pass. Opening channels is how nerve cells make electrical signals. - **Action potential**: The brief electrical spike a nerve cell fires to send a message along its length to other cells. - **Retinal**: The small light-catching molecule bound inside rhodopsins. Absorbing light changes its shape, which opens the channel. - **Chlamydomonas**: A single-celled green alga that swims toward light. It senses light with an eyespot, where channelrhodopsins sit. - **Halorhodopsin**: A light-driven chloride pump from salt-loving microbes. In nerve cells it works as an off switch under yellow light. - **Engram**: The group of nerve cells that physically stores a particular memory. ## Check yourself 1. What does channelrhodopsin-2 do when blue light hits it? - It pumps ions out of the cell - **It opens a channel that lets positive ions flow in** (correct) - It releases a chemical messenger - It makes the cell glow - Why: Channelrhodopsin-2 is **a light sensor and an ion channel in one protein**. Light opens the pore and positive ions flow into the cell. In a nerve cell that inflow can trigger an action potential. 2. Why was a protein from an alga better than earlier ways of making neurons respond to light? - It needed three genes working together - It required a synthetic chemical injected into the brain - **It was a single gene that turned light into current within milliseconds** (correct) - It only worked in frog eggs - Why: Earlier systems needed several genes or an added chemical, and they were too slow for the millisecond timing of nerve signals. Channelrhodopsin-2 is **one protein from one gene** that converts light straight into current, and the small amount of retinal already in animal cells is enough. 3. What is the honest status of optogenetics as a treatment for blindness today? - It is an approved, routine therapy - **It is in early trials and has partly restored vision in some patients using special goggles** (correct) - It has restored normal reading vision - It has never been tried in a person - Why: In 2021 a blind patient with retinitis pigmentosa regained **partial** vision, enough to tell high-contrast objects apart with light-projecting goggles. It remains experimental. ## The laureates ### Karl Deisseroth Karl Deisseroth (born 1971) trained in medicine and neuroscience at Stanford, and his time on a psychiatric ward pushed him to study how living brains go wrong. In 2005 his lab showed that the algal channel could make rat nerve cells fire on cue with blue light. In 2007 it moved the whiskers of living mice with light sent down a thin optical fibre. He also helped coin the name optogenetics in 2006. ### Peter Hegemann Peter Hegemann (born 1954) wanted to know how a single-celled green alga reacts to light so fast. At the Max Planck Institute for Biochemistry in Martinsried he measured its electrical response and, in the early 1990s, proposed that one protein both catches the light and forms the ion channel. Colleagues were sceptical. Years later his group found the alga genes that proved him right. ### Georg Nagel Georg Nagel (born 1953) was an expert at making frog eggs produce foreign membrane proteins so he could measure their currents. At the Max Planck Institute of Biophysics in Frankfurt he showed in 2002 and 2003 that Hegemann's alga genes code for light-gated ion channels, now called channelrhodopsins. He then sent the gene to Deisseroth's lab, which put it into nerve cells. ## Sources - [The Nobel Prize in Physiology or Medicine 2026, popular science background (NobelPrize.org)](https://www.nobelprize.org/prizes/medicine/2026/popular-information/) - [Press release: The Nobel Prize in Physiology or Medicine 2026 (NobelPrize.org)](https://www.nobelprize.org/prizes/medicine/2026/press-release/) - [Scientific background: Optogenetics, discovery of a neuronal switch (NobelPrize.org, pdf)](https://www.nobelprize.org/uploads/2026/10/advanced-medicineprize2026.pdf) - [Channelrhodopsin (Wikipedia)](https://en.wikipedia.org/wiki/Channelrhodopsin) - [Optogenetics (Wikipedia)](https://en.wikipedia.org/wiki/Optogenetics) - [Sahel et al. 2021, Partial recovery of visual function in a blind patient after optogenetic therapy (Nature Medicine, PubMed)](https://pubmed.ncbi.nlm.nih.gov/34031601) - [Optogenetic therapy shows early signs of improving vision in inherited blindness (Medical Xpress, 2026)](https://medicalxpress.com/news/2026-10-optogenetic-therapy-early-vision-inherited.html) --- From Nobel Explained (https://nobelexplained.com), a free, independent course on every Nobel Prize since 2020. Not affiliated with the Nobel Foundation. Facts are pinned from the official Nobel Prize API.